- Home
- PSNL vs PDT Comparison
PSNL vs PDT Comparison
Compare PSNL & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSNL | PDT |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.1M | 653.2M |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PSNL | PDT |
|---|---|---|
| Price | $7.77 | $13.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.20 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 92.7K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,648,000.00 | N/A |
| Revenue This Year | $15.47 | N/A |
| Revenue Next Year | $39.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.83 | $11.41 |
| 52 Week High | $11.50 | $13.65 |
Technical Indicators
Market Signals| Indicator | PSNL | PDT |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 42.66 |
| Support Level | $7.74 | $12.99 |
| Resistance Level | $7.78 | $13.20 |
| Average True Range (ATR) | 0.53 | 0.16 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 63.83 | 37.50 |
Price Performance
Historical ComparisonAbout PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About PDT John Hancock Premium Dividend Fund
John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest capital growth. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.